Expanded service BASi offers both contract laboratory services and in-house instrument manufacturing across biotech research, presenting opportunities to upsell integrated analytical services and instrument adoption for clients seeking end-to-end solutions.

Growth next steps With recent leadership additions in operations, pathology, surgical models, and human resources, there is momentum for strategic account expansion, cross-selling programmatic CRO services, and deeper client engagement in regulated pharma projects.

Mid-market focus Company size and revenue position BASi in the mid-market contract research space, suggesting viable targets among mid-to-large biotech and pharma firms seeking cost-effective, scalable nonclinical and analytical capabilities.

Global capability As a provider serving pharmaceutical research worldwide, BASi’s global reach can be leveraged to pursue multinational sponsors needing consistent, cross-border preclinical testing, DMPK, pathology, and surgical models.

Innovation push BASi emphasizes developing innovative services and cost-reducing offerings, creating selling points around efficiency gains and accelerating drug development timelines for potential customers.